Journal
INFLAMMATORY BOWEL DISEASES
Volume 18, Issue 1, Pages 49-54Publisher
OXFORD UNIV PRESS INC
DOI: 10.1002/ibd.21669
Keywords
NAFLD; NASH; IBD; Crohn's disease; liver
Categories
Funding
- National Institutes of Health [T32 DK07634, 1KL2-RR025746-03]
- CCFA
- NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025746] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007634] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Background: With improvements in therapy for inflammatory bowel disease (IBD) and changes in the prevalence of obesity, the phenotype of Crohn's disease (CD) is changing. These changes may herald an increase in the incidence of nonalcoholic fatty liver disease (NAFLD) in this population.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available